Sherman, Kenneth
University of Cincinnati Medical Center
4 papers on CoChatORCID 0000-0002-0560-0019
Most cited papers
- Verified
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 1,277
- Verified
Hepatitis C virus infection in USA: an estimate of true prevalence
Chak, E., Talal, A. H., Sherman, K. E., Schiff, E. R., & Saab, S. (2011) · Liver International
Hepatitis C virus researchHelicobacter pylori-related gastroenterology studies
Cited by 396
- Verified
The cost-effectiveness of screening for chronic hepatitis B infection in the United States
Eckman, M. H., Kaiser, T. E., & Sherman, K. E. (2011) · Clinical Infectious Diseases
Hepatitis B Virus StudiesHealth Systems, Economic Evaluations, Quality of Life
Cited by 80
- Verified
Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults
Yeboah-Korang, A., Memon, A., Patel, N., Portocarrero-Castillo, A., Osman, A., Kleesattel, D., Lopez, C., Louissaint, J., Sherman, K., & Fontana, R. (2022) · Digestive Diseases and Sciences
Drug-Induced Hepatotoxicity and ProtectionDrug-Induced Adverse Reactions
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free